New Merck: About 500 Legacy Organon R&D Jobs To Stay In The Netherlands

Candidly, this is actually quite a bit better news than I had expected. Merck will keep some R&D jobs open in Oss, per Reuters reporting this morning:

. . . .Organon said on Thursday that Merck has now agreed to keep 486 of the 1000 research and development jobs in the Netherlands, and to set up a new Dutch research centre focused on supporting all of Merck’s therapeutic areas as well as emerging economies. . . .

Separately, FDA denied Merck’s application to expand the label for Gardasil, to older women in the US.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s